US3658070A - Tobacco smoke filters - Google Patents
Tobacco smoke filters Download PDFInfo
- Publication number
- US3658070A US3658070A US77247A US3658070DA US3658070A US 3658070 A US3658070 A US 3658070A US 77247 A US77247 A US 77247A US 3658070D A US3658070D A US 3658070DA US 3658070 A US3658070 A US 3658070A
- Authority
- US
- United States
- Prior art keywords
- smoke
- dppd
- filter
- tobacco smoke
- cigarette
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000779 smoke Substances 0.000 title claims abstract description 103
- 235000002637 Nicotiana tabacum Nutrition 0.000 title claims abstract description 27
- 244000061176 Nicotiana tabacum Species 0.000 title 1
- 241000208125 Nicotiana Species 0.000 claims abstract description 26
- 229920002301 cellulose acetate Polymers 0.000 claims abstract description 15
- 239000000463 material Substances 0.000 claims abstract description 13
- 239000000203 mixture Substances 0.000 claims abstract description 9
- 206010068887 Tobacco poisoning Diseases 0.000 claims abstract description 6
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims description 48
- 229960003180 glutathione Drugs 0.000 claims description 26
- 108010024636 Glutathione Proteins 0.000 claims description 24
- 231100000331 toxic Toxicity 0.000 claims description 16
- 230000002588 toxic effect Effects 0.000 claims description 16
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 11
- 238000001914 filtration Methods 0.000 claims description 8
- 239000012876 carrier material Substances 0.000 claims description 5
- UTGQNNCQYDRXCH-UHFFFAOYSA-N N,N'-diphenyl-1,4-phenylenediamine Chemical compound C=1C=C(NC=2C=CC=CC=2)C=CC=1NC1=CC=CC=C1 UTGQNNCQYDRXCH-UHFFFAOYSA-N 0.000 abstract description 52
- 210000004072 lung Anatomy 0.000 abstract description 10
- 210000002540 macrophage Anatomy 0.000 abstract description 10
- 239000003610 charcoal Substances 0.000 abstract description 4
- 235000019504 cigarettes Nutrition 0.000 description 60
- 239000003963 antioxidant agent Substances 0.000 description 45
- 235000006708 antioxidants Nutrition 0.000 description 43
- 230000003078 antioxidant effect Effects 0.000 description 36
- 235000003969 glutathione Nutrition 0.000 description 23
- 210000001132 alveolar macrophage Anatomy 0.000 description 22
- 239000000243 solution Substances 0.000 description 18
- 239000000126 substance Substances 0.000 description 18
- 239000000284 extract Substances 0.000 description 12
- 241000700159 Rattus Species 0.000 description 11
- 150000002632 lipids Chemical class 0.000 description 10
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- 239000006286 aqueous extract Substances 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 9
- 230000035899 viability Effects 0.000 description 9
- 239000012887 cigarette smoke extract Substances 0.000 description 7
- 230000007423 decrease Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 230000001665 lethal effect Effects 0.000 description 6
- 150000003254 radicals Chemical class 0.000 description 6
- 230000001681 protective effect Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- 229910019142 PO4 Inorganic materials 0.000 description 4
- 230000003833 cell viability Effects 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 4
- 239000010452 phosphate Substances 0.000 description 4
- UXKQNCDDHDBAPD-UHFFFAOYSA-N 4-n,4-n-diphenylbenzene-1,4-diamine Chemical compound C1=CC(N)=CC=C1N(C=1C=CC=CC=1)C1=CC=CC=C1 UXKQNCDDHDBAPD-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 238000005470 impregnation Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000002186 photoactivation Effects 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- -1 DPPD lipid Chemical class 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 239000013043 chemical agent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 231100000433 cytotoxic Toxicity 0.000 description 2
- 230000001472 cytotoxic effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007123 defense Effects 0.000 description 2
- 231100000673 dose–response relationship Toxicity 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000007792 gaseous phase Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 231100000225 lethality Toxicity 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 230000002685 pulmonary effect Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- CNRNYORZJGVOSY-UHFFFAOYSA-N 2,5-diphenyl-1,3-oxazole Chemical compound C=1N=C(C=2C=CC=CC=2)OC=1C1=CC=CC=C1 CNRNYORZJGVOSY-UHFFFAOYSA-N 0.000 description 1
- LKALLEFLBKHPTQ-UHFFFAOYSA-N 2,6-bis[(3-tert-butyl-2-hydroxy-5-methylphenyl)methyl]-4-methylphenol Chemical compound OC=1C(CC=2C(=C(C=C(C)C=2)C(C)(C)C)O)=CC(C)=CC=1CC1=CC(C)=CC(C(C)(C)C)=C1O LKALLEFLBKHPTQ-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 101100264195 Caenorhabditis elegans app-1 gene Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241001286408 Gretna Species 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 229920001131 Pulp (paper) Polymers 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000007541 cellular toxicity Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000019506 cigar Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- BCGWQEUPMDMJNV-UHFFFAOYSA-N imipramine Chemical compound C1CC2=CC=CC=C2N(CCCN(C)C)C2=CC=CC=C21 BCGWQEUPMDMJNV-UHFFFAOYSA-N 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000005567 liquid scintillation counting Methods 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000009826 neoplastic cell growth Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 239000004627 regenerated cellulose Substances 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24D—CIGARS; CIGARETTES; TOBACCO SMOKE FILTERS; MOUTHPIECES FOR CIGARS OR CIGARETTES; MANUFACTURE OF TOBACCO SMOKE FILTERS OR MOUTHPIECES
- A24D3/00—Tobacco smoke filters, e.g. filter-tips, filtering inserts; Filters specially adapted for simulated smoking devices; Mouthpieces for cigars or cigarettes
- A24D3/06—Use of materials for tobacco smoke filters
- A24D3/14—Use of materials for tobacco smoke filters of organic materials as additive
Definitions
- ABSTRACT A tobacco smoke filter filled with a smoke permeable composition capable of reducing the toxic effect of tobacco smoke on alveolar (lung) macrophages, comprising N,N'-diphen ⁇ 'l-pphenylenediamine (DPPD) which may be mixed with flutathione, active charcoal or mixed with or impregnated into known filter material such as cellulose acetate.
- DPPD N,N'-diphen ⁇ 'l-pphenylenediamine
- the present invention relates to tobacco smoke filters which are suitable for employment in cigarettes, pipes, cigarette holders or cigar holders.
- the present filter classified as a chemical filter, has profound advantages over other filters knownto the art by being able to modify the toxic and/or lethal effects of cigarette smoke extracts on alveolar macrophages, the primary host defense cell ofthe lung.
- the filters currently available are essentially employed to remove particulate and solid components of smoke as well as to dilute the gaseous components of smoke with air.
- the gaseous phase of the smoke readily passes through such filters resulting in irritation to the lung tissue and, as will'be noted later, profound lethality to isolated alveolar macrophages, a cell whose primary function is to maintain a proper lung environment by detoxification and destroying a variety of agents.
- the gases derived from burning tobacco smoke contain highly reactive, low molecular weight, volatile components, of which acetaldehyde is characteristic, as well as free radicals and large quantities of gaseous ions induced by the high temperatures, which can approach l,000 C resulting in pyrolization and distillation.
- the chemical filtering material incorporated in the present invention has the ability, in the classical role of antioxidants as free radical stoppers, to lower the cytotoxic substances of cigarette smoke, possibly by reducing the attack of free radicals or other such reactive agents on pulmonary alveolar cells and therefore maintaining cell viability. Since free radicals have been implicated in the genesis of neoplasia, a beneficial effect of the antioxidant filler may be implied.
- the chemical filter has the ability to prevent smoke-induced decreases in circulating plasma lipid antioxidants.
- a tobacco smoke filter such as a cylindrical container filled with a smoke permeable composition comprising the lipid soluble antioxidant N,N'-diphenyl-p-phenylenediamine (DPPD), preferably mixed with the water soluble antioxidant glutathione.
- DPPD or the DPPD mixed with glutathione may be used alone or mixed with other ingredients such as with activated charcoal or impregnated into a filter carrier material such as cellulose acetate, paper, wood pulp, cotton, fibrous polyolefins, cellulose esters in fibrous or plastic form, regenerated cellulose, silica gel, alumina, tobacco and the like.
- the DPPD may be mixed with other chemical filters such as the amide filter of U.S. Pat. No. 3,426,765.
- the amount of DPPD required to be effective in reducing the toxic effect of tobacco smoke on alveolar (lung) macrophages is from 0.025 to 0.500 grams in a filter for use in cigarettes and pipes, irrespective of the type and size of the cigarette or pipe in present day use. Preferably the amount will be from 0.050 to 0.200 grams.
- the percentage of DPPD with carrier material is preferably from 5 70 per cent by weight based on the weight of carrier material, although higher amounts may, of course, be present since the invention is operative with 100 per cent DPPD.
- the proportion of glutathione to DPPD may vary widely up to a weight ratio of lO-lor higher, but preferably the glutathione, in order to give increased effectiveness to the DPPD, should be present in a ratio of at least l-l0.
- the weight ration likewise may vary up to a ratio of activated carbon to DPID of l-l or higher, preferably 0.5-l to -1.
- FIG. 1, FIG. 2 and FIG. 3 show views in elevation, partly in section, of cigarettes having different arrangements of filters and different types of chemical filter compositions.
- the numeral 10 represents a cigarette consisting of a paper tube 11 packed, except for tip tip portion, with tobacco 16.
- One end ofthe paper tube 11 (or a separate butt tube) consists of a section 12 composed of particles of DPPD with or without glutathione between filter sections 13 and 14 composed of cellulose acetate or other known tobacco smoke filter material.
- the section 12 may also contain DPPD mixed with active charcoal creating a simultaneous mechanical and chemical filter having dual advantages.
- the numerals l0, l1 and 16 are the same'as in FIG. 1 and the section 12 is composed of a cellulosic filter material impregnated with DPPD, with a plain cellulosic filter 13 at the tip ofthe cigarette. l
- the numerals l0, l1 and 16 are the same as in FIG. I and the numeral 12 represents cellulosic filter material or other absorbent filter material impregnated with DPPD with or without glutathione.
- the numeral 15 represents a recess portion of the tip of the cigarette.
- the DPPD and DPPD with glutathione additives specifcally employed to reduce the toxic effects of cigarettes on alveolar (lung) macrophages will also restrict certain biochemical changes which occur following exposure of animals and humans to cigarette smoke. These antioxidant filters will contribute to the reduction of chronic pulmonary disease, which can be credited to impaired macrophage function.
- the DPPD antioxidant permits to superimposition of a technique which might be described as "selective chemical filtration onto the current commonly used process of mechanical filtration.
- Alveolar macrophages were isolated from rat lungs by the technique oflung washing and equal aliquots ofobtained cells were added to three flasks containing the following:
- Flask A 3 ml ofKrebs-Ringer Phosphate Medium (KRP). Flask B. 2.9 ml of KRP plus 0.1 ml ofKRP smoke solution. Flask C. 2.5 ml of KRP plus 0.5 ml of KRP smoke solution. Flask D. 2.0 ml of KRP plus l.0 ml of KRP smoke solution.
- the KRP smoke solution was prepared by bubbling through 10 ml of KRP solution the smoke from one unfiltered cigarette. This solution was used within 10 minutes of its Experiment I Experiment ll Cell Cell Smoke Survival, Survival, Percent Flask Solution 7: 30 Min. 30 Min. 60 Min.
- Rat alveolar macrophages 7.5 X 10 macrophages per flask, were incubated in the presence or absence of aqueous extracts of cigarette smoke prepared as Example 1 from one unfiltered cigarette.
- FIG. 1 An antioxidant filter was designed and developed (FIG. 1), consisting of 100 mg ofantioxidant filter (50 mg of glutathione and 50 mg of N,N-diphenyl-p-phenylenediamine (DPPD). Control filters were employed using non-antioxidant chemicals, such as sodium chloride (50 mg), and sodium bicarbonate (50 mg), which have comparable physical appearances of the antioxidants. These filters are designated as Inert Chemical Filters, having no antioxidant activity. Aqueous extracts were prepared using the following type cigarettes:
- Cigarettes Control lnert or Non-antioxidant Containing Chemical Filtered Cigarettes.
- aqueous smoke extracts were prepared and added in the amount of 1 ml to incubation flasks containing 1.2 X alveolar macrophage cells isolated from rat lungs. lncubations' were carried out at 37 C for 0, 60 and 120 minutes and cell viability determined at each period by means of the trypan blue exclusion test. The following data were obtained:
- DPPD antioxidant an important host defense cell of the body, function in phagocytosis and destruction of bacteria, viruses altered or aged cells, as well as the removal and digestion of toxic macromolecular compounds which are present in their environment.
- DPPD antioxidant with glutathione impregnated on cellulose acetate filters (FIGS. 2 and 3), in maintaining alveolar macrophage viability was also tested.
- a Krebs- Ringer phosphate medium was prepared, which had a concentration of 50 mg of glutathione and 50 mg of DPPD/per milliliter.
- the sectioned filters were immersed in the aqueous suspension for one minute, removed and dried under vacuum overnight. The approximate total uptake of antioxidants by each filter was 100 mg.
- the protective effect of the DPPD-glutathione filter was due principally to the DPPD, since glutathione did not exert any protective activity on maintaining alveolar macrophage viability in the presence of aqueous smoke extracts.
- charcoal-cellulose acetate filter was effective in reducing the increase in photoactivation when compared to the unfiltered cigarette; however, the activity was twice that observed when the chemical antioxidant filter was employed.
- the activated carbon plus antioxidant filter prepared as previously described, complete suppression oflight energy from the aqueous solution was obtained.
- Plasma and tissue lipid soluble antioxidant activity was determined in normal, untreated control rats, and in rats exposed to smoke from five unfiltered cigarettes.
- groups of rats were also exposed to smoke from five regular filter (cellulose acetate) cigarettes and to smoke derived from five antioxidant filter (FIG. 1) cigarettes.
- Values below are listed as means standard error of mean and are derived from groups of rats number from 6 to 13.'Values of DPPD lipid antioxidants are expressed as microequivalents of antioxidant per milliliter of plasma or per gram of tissue.
- a novel filter comprising the lipid soluble antioxidant DPPD which can be readily adapted to reduce the toxicity of cigarette smoke.
- This chemical antioxidant additive can readily be incorporated by impregnation into conventional type filters or as inserts into conventional filters.
- the resulting cigarette which has been smoked by the investigator and others, is a mild, pleasant smoke without appreciable loss of flavor or aroma.
- a tobacco smoke filter comprising a cylindrical container having a cross-sectional dimension conforming to that of a tobacco smoke passage and defining a space having an inlet and outlet, said space being filled with a smoke permeable composition comprising N,N-diphenyl-p-phenylenediamine in an amount from about 0.025 to 0.500 grams to reduce the toxic effect of tobacco smoke passing through the container on alveolar macrophages, the amount used not being toxic to the smoker.
- a tobacco smoke filter according to claim 1 in which the N,N-diphenylp-phenylenediamine is mixed with glutathione.
- a tobacco smoke filter according to claim 2 wherein the mixture is impregnated into a cellulose acetate filtering material.
- a tobacco smoke filter adapted to remove undesirable components from tobacco smoke, said filter having a crosssectional dimension conforming to that of a tobacco smoke passage and comprising a carrier material and an amount of from 5 per cent to 70 per cent by weight based on the weight of said carrier of N,N'-diphenyl-p-phenylenediamine to reduce the toxic effect of tobacco smoke passing through said passage, the amount used not being toxic to the smoker.
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Cigarettes, Filters, And Manufacturing Of Filters (AREA)
Abstract
A tobacco smoke filter filled with a smoke permeable composition capable of reducing the toxic effect of tobacco smoke on alveolar (lung) macrophages, comprising N,N''-diphenyl-p-phenylenediamine (DPPD) which may be mixed with flutathione, active charcoal or mixed with or impregnated into known filter material such as cellulose acetate.
Description
United States Patent Diluzio [151 3,658,070 [4:] Apr. 25, 1972 [54] TOBACCO SMOKE FILTERS [72] Inventor: Nicholas R. Diluzlo, 732 Fairfield Avenue,
Gretna, La. 70053 [22] Filed: Oct. 1, 1970 [21] App1.No.: 77,247
[52] U.S.Cl ..131/267, 131/107, 131/109, 131/265 [51] Int. Cl ..A24b 15/02, A24d 01/06 [58] Field of Search 131/10 R, 266, 267, 269, 262 A, 131/261 [56] References Cited UNITED STATES PATENTS 1,842,266 1/1932 Hicks... ..131/17 R 2,152,602 3/1939 Ott ...13l/17RX 2,513,002 6/1950 Chenicek ...l3l/17 R X 2,968,306 ..131/266 1/1961 Tovey et a1,
Primary Examiner-Samuel Koran Assistant Examiner-G. M. Yahwak Attorney-label, Baker, York and Jones [57] ABSTRACT A tobacco smoke filter filled with a smoke permeable composition capable of reducing the toxic effect of tobacco smoke on alveolar (lung) macrophages, comprising N,N'-diphen \'l-pphenylenediamine (DPPD) which may be mixed with flutathione, active charcoal or mixed with or impregnated into known filter material such as cellulose acetate.
6 Claims, 3 Drawing Figures PATENTEDAPR 2 5 m2 INVENTOR NICHOLAS R. D! LUZ/O yw'vs TOBACCO SMOKE FILTERS The present invention relates to tobacco smoke filters which are suitable for employment in cigarettes, pipes, cigarette holders or cigar holders.
The present filter, classified as a chemical filter, has profound advantages over other filters knownto the art by being able to modify the toxic and/or lethal effects of cigarette smoke extracts on alveolar macrophages, the primary host defense cell ofthe lung.
.The filters currently available are essentially employed to remove particulate and solid components of smoke as well as to dilute the gaseous components of smoke with air. The gaseous phase of the smoke readily passes through such filters resulting in irritation to the lung tissue and, as will'be noted later, profound lethality to isolated alveolar macrophages, a cell whose primary function is to maintain a proper lung environment by detoxification and destroying a variety of agents.
The gases derived from burning tobacco smoke contain highly reactive, low molecular weight, volatile components, of which acetaldehyde is characteristic, as well as free radicals and large quantities of gaseous ions induced by the high temperatures, which can approach l,000 C resulting in pyrolization and distillation.
In addition, free radicals which have been demonstrated to be cytotoxic have also been demonstrated to occur in the gaseous phase of smoke. The chemical filtering material incorporated in the present invention has the ability, in the classical role of antioxidants as free radical stoppers, to lower the cytotoxic substances of cigarette smoke, possibly by reducing the attack of free radicals or other such reactive agents on pulmonary alveolar cells and therefore maintaining cell viability. Since free radicals have been implicated in the genesis of neoplasia, a beneficial effect of the antioxidant filler may be implied. In addition, the chemical filter has the ability to prevent smoke-induced decreases in circulating plasma lipid antioxidants.
' It is the object of the present invention to provide a filter which, I have discovered, reduces the disclosed toxicity of cigarette smoke on alveolar macrophages.
l have discovered that the above object can be accomplished by having a tobacco smoke filter such as a cylindrical container filled with a smoke permeable composition comprising the lipid soluble antioxidant N,N'-diphenyl-p-phenylenediamine (DPPD), preferably mixed with the water soluble antioxidant glutathione. The DPPD or the DPPD mixed with glutathione may be used alone or mixed with other ingredients such as with activated charcoal or impregnated into a filter carrier material such as cellulose acetate, paper, wood pulp, cotton, fibrous polyolefins, cellulose esters in fibrous or plastic form, regenerated cellulose, silica gel, alumina, tobacco and the like. Likewise the DPPD may be mixed with other chemical filters such as the amide filter of U.S. Pat. No. 3,426,765.
The amount of DPPD required to be effective in reducing the toxic effect of tobacco smoke on alveolar (lung) macrophages is from 0.025 to 0.500 grams in a filter for use in cigarettes and pipes, irrespective of the type and size of the cigarette or pipe in present day use. Preferably the amount will be from 0.050 to 0.200 grams.
The percentage of DPPD with carrier material is preferably from 5 70 per cent by weight based on the weight of carrier material, although higher amounts may, of course, be present since the invention is operative with 100 per cent DPPD.
The proportion of glutathione to DPPD may vary widely up to a weight ratio of lO-lor higher, but preferably the glutathione, in order to give increased effectiveness to the DPPD, should be present in a ratio of at least l-l0.
When active carbon is present the weight ration likewise may vary up to a ratio of activated carbon to DPID of l-l or higher, preferably 0.5-l to -1.
Other chemical filtering material may be used in varying amounts, but preferably the DPPD should be present in major amount compared to other material.
The invention is illustrated by reference to the accompanying drawing in which FIG. 1, FIG. 2 and FIG. 3 show views in elevation, partly in section, of cigarettes having different arrangements of filters and different types of chemical filter compositions.
In FIG. I the numeral 10 represents a cigarette consisting of a paper tube 11 packed, except for tip tip portion, with tobacco 16. One end ofthe paper tube 11 (or a separate butt tube) consists ofa section 12 composed of particles of DPPD with or without glutathione between filter sections 13 and 14 composed of cellulose acetate or other known tobacco smoke filter material. The section 12 may also contain DPPD mixed with active charcoal creating a simultaneous mechanical and chemical filter having dual advantages.
In FIG. 2 the numerals l0, l1 and 16 are the same'as in FIG. 1 and the section 12 is composed of a cellulosic filter material impregnated with DPPD, with a plain cellulosic filter 13 at the tip ofthe cigarette. l
In FIG. 3 the numerals l0, l1 and 16 are the same as in FIG. I and the numeral 12 represents cellulosic filter material or other absorbent filter material impregnated with DPPD with or without glutathione. The numeral 15 represents a recess portion of the tip of the cigarette.
Rearrangements of the various combinations shown in the drawings may, of course, be made, and it is not necessary that there be any filter other than the composition consisting of or comprising DPPD.
By having a plain (nonchemical) filter at the tip of the cigarette (FIGSpl and 2) no contact of the smoke with the chemical agent occurs. Likewise, the use ofa recess portion of the tip (FIG. 3) will prevent contact of the smoker with the chemical agent.
The DPPD and DPPD with glutathione additives specifcally employed to reduce the toxic effects of cigarettes on alveolar (lung) macrophages will also restrict certain biochemical changes which occur following exposure of animals and humans to cigarette smoke. These antioxidant filters will contribute to the reduction of chronic pulmonary disease, which can be credited to impaired macrophage function.
The DPPD antioxidant permits to superimposition of a technique which might be described as "selective chemical filtration onto the current commonly used process of mechanical filtration. Having in a general way indicated the nature and purpose of my invention, the following are examples and data by which specific illustrations of the practice of the invention and the advantages to be obtained are demonstrated and are not to be construed as limiting the same.
EXAMPLE 1 Toxic Effects of aqueous Extracts of Cigarette Smoke on Isolated Alveolar Macrophages.
Alveolar macrophages were isolated from rat lungs by the technique oflung washing and equal aliquots ofobtained cells were added to three flasks containing the following:
Flask A. 3 ml ofKrebs-Ringer Phosphate Medium (KRP). Flask B. 2.9 ml of KRP plus 0.1 ml ofKRP smoke solution. Flask C. 2.5 ml of KRP plus 0.5 ml of KRP smoke solution. Flask D. 2.0 ml of KRP plus l.0 ml of KRP smoke solution.
The KRP smoke solution was prepared by bubbling through 10 ml of KRP solution the smoke from one unfiltered cigarette. This solution was used within 10 minutes of its Experiment I Experiment ll Cell Cell Smoke Survival, Survival, Percent Flask Solution 7: 30 Min. 30 Min. 60 Min.
A 0 74.2 69.3 B 0.l mi 72.2 74.5 66.2 C 0.5 ml H9 203 These studies, as well as those to follow, clearly denote the aqueous extracts of cigarette smoke exert a lethal effect on isolated rat alveolar macrophages which is dose dependent. While no reduction in viability was observed when 0.1 ml of smoke solution was added, a 42 and 71 per cent decrease in viability was observed at 30 and 60 minutes, respectively upon the addition of 0.5 ml of smoke solution. When 1.0 ml of smoke solution was added, or a volume equivalent to 0.1 of the original smoke extract obtained from one cigarette, an almost total loss of viability was observed. Thus, exposure of alveolar macrophages to gaseous, water soluble elements of cigarette smoke is associated with significant cellular mortality.
EXAMPLE 2 Further Studies on the the Toxic Effect of Cigarette Smoke.
Additional studies were conducted on the effects of varying concentrations of cigarette smoke on alveolar macrophage viability. Rat alveolar macrophages, 7.5 X 10 macrophages per flask, were incubated in the presence or absence of aqueous extracts of cigarette smoke prepared as Example 1 from one unfiltered cigarette.
These studies confirm the dose dependent toxic effect of aqueous extracts of cigarette smoke on isolated lung macrophages.
EXAMPLE 3 Modification of Toxic Effects of Cigarette Smoke by Antioxidant Filter.
In view of the definitive toxic effects of cigarette smoke extract on isolated alveolar macrophages, attempts were made to modify the toxic effects of smoke extract on alveolar macrophages. .An antioxidant filter was designed and developed (FIG. 1), consisting of 100 mg ofantioxidant filter (50 mg of glutathione and 50 mg of N,N-diphenyl-p-phenylenediamine (DPPD). Control filters were employed using non-antioxidant chemicals, such as sodium chloride (50 mg), and sodium bicarbonate (50 mg), which have comparable physical appearances of the antioxidants. These filters are designated as Inert Chemical Filters, having no antioxidant activity. Aqueous extracts were prepared using the following type cigarettes:
A. Nonfiltered Cigarettes.
B. Antioxidant Filtered Cigarettes.
C. Control lnert or Non-antioxidant Containing Chemical Filtered Cigarettes. D. Regular Commercial Cigarettes.
The aqueous smoke extracts were prepared and added in the amount of 1 ml to incubation flasks containing 1.2 X alveolar macrophage cells isolated from rat lungs. lncubations' were carried out at 37 C for 0, 60 and 120 minutes and cell viability determined at each period by means of the trypan blue exclusion test. The following data were obtained:
Cellulose Acetate Filtered Cell viability, percent Smoke Flask Filter extract 0 min. 60 min. 120 min.
A. 74. 5 6-1. 4 B 17. S 0. O- Antioxidant 71.0 17. (l D Inert chemical- 43.1 1. 8 E. Cellulose acetat 33. 7 4. 5 A... 77.7 611.4 E. 41.7 1. 8 C Antioxidant 80. 2 41. 3 D Inert chemical. 49. 5 0 E Cellulose acetate. 33. 7 0. 97
These studies clearly denote the toxic lethal effects of cigarette smoke extract on cell viability as essentially 100 per cent mortality of alveolar macrophages is observed after 2 hours of incubation (B GROUP). During the initial hour ofincubation, the mean 62 per cent decrease in viability, which characterized the cells incubated in aqueous extracts, was not observed when the antioxidant chemical filter consisting of equal parts of DPPD and glutathione was employed. Significant protective effects are observed at the minute period when the antioxidant filter is employed. Likewise, essentially 100 per cent mortality was seen in the cells incubated with aqueous extracts of cigarette smoke derived from filtered cigarettes, chemical control filtered cigarettes, i.e., the nonantioxidant type filter, and the nonfiltered cigarette.
Thus, the beneficial effect of DPPD antioxidant on negating the toxic effect of cigarette smoke on lungmacrophages is manifested. These macrophages, an important host defense cell of the body, function in phagocytosis and destruction of bacteria, viruses altered or aged cells, as well as the removal and digestion of toxic macromolecular compounds which are present in their environment.
EXAMPLE 4 The influence'of Antioxidant impregnated Filters on Alveolar Macrophage Viability.
The effect of DPPD antioxidant with glutathione impregnated on cellulose acetate filters (FIGS. 2 and 3), in maintaining alveolar macrophage viability was also tested. Our tests indicated that approximately 1 ml of Krebs-Ringer phosphate solution is taken up by a cellulose acetate filter, which were sectioned to enhance surface area. A Krebs- Ringer phosphate medium was prepared, which had a concentration of 50 mg of glutathione and 50 mg of DPPD/per milliliter. The sectioned filters were immersed in the aqueous suspension for one minute, removed and dried under vacuum overnight. The approximate total uptake of antioxidants by each filter was 100 mg. Filters prepared in such a fashion were then inserted back into the end of the cigarette from which the filters were originally removed and aqueous extracts of cigarette smoke prepared from the resulting cigarettes as previously described. Incubation of the aqueous smoke extracts were isolated macropages were conducted at 37 C for 60 and 120 minutes. The results are as follows:
These studies, in essential agreement with previous observations, clearly demonstrate the toxicity of cigarette smoke (group B) and the inability of currently employed filters (group D) to modify the lethal action of cigarette smoke on alveolar macrophages. ln profound contrast, the impregnation of DPPD and glutathione antioxidants into a cellulose acetate filter results in complete inhibition of the lethal effects of cigarette smoke extract (group C).
The protective effect of the DPPD-glutathione filter was due principally to the DPPD, since glutathione did not exert any protective activity on maintaining alveolar macrophage viability in the presence of aqueous smoke extracts. These findings are presented in the following table. As can be observed, the incorporation of glutathione with DPPD resulted filter impregnation.
in enhancement in survival of the smoke exposed pulmonary trapped in 10 milliliters of KRP solution and its macrophages. This suggests a synergistic action between the phosphorescene activity determined prior to, and after, the lipid soluble and water soluble antioxidant on maintaining puladdition of 1 ml of ml peroxide. The hydrogen peroxide was monary macrophage viability. The DPPD filter was found to added to 1 ml of solution prepared from unfiltered cigarette be equally effective if the DPPD was suspended either in water 5 smoke, antioxidant filtered, commercial charcoal filtered, and
to impregnate the filter or dissolved in ethyl alcohol prior to a combination ofcharcoal plus glutathione and DPPD antioxi- 1 dant mixture and counted one minute later by means of a liquid scintillation system. The addition of hydrogen peroxide lNFLUEN E OF DPPD AND GLUTATHIONE ALONE OR results in immediate emission of electromagnetic radiation, or
CONJOINTLY 0N ALVEOLAR MACROPHAGE 10 light, from as yet an unidentified compound present in the VlABlLlTY lN THE PRESENCE OF AQUEOUS SMOKE smoke extract EXTRACT These studies, and those conducted with toluene trapping solutions, indicate that unknown phosphorescent substances are present in cigarette smoke extracts which produce vlabllltyphotons. The excited molecular species, as yet unidentified,
Smoke Incubation Time Filter Extra 0 Min 60 Min product light quanta which can be detected by a phototube of a liquid scintillation counting system. The energy of the excited molecular species is appreciably below that of Triti- 85 um, i.e., less than 0.018 MEV. It can be noted in the table below that the Krebs-Ringer Cellulose Acetate l4 DPRD. 33 Phosphate buffer had background activity (l0-20counts per DPPD" 34 minute). Similarly, in aqueous solutions, like Krebs-Ringer DPPD Glutathio I Phosphate medium, the smoke solutions prepared from the Glumhmne various filters were comparable. However. when hydrogen I peroxide was added to various KRP-smoke solutions, an ap- DPPD s) p p as \valetiuspsnsion imprssnale filtsrproximate twentyfold increase occurred in the photon producxx DPPD 100 mg) dissolved in ethyl alcohol to impregnate filter. i ti it f the am le This contrasted markedly to but a m DPPD and gluwhioneiw s mdmimp'egnae fourfold increase when DPPD plus glutathione was employed in the filter to prepare the KRP smoke solution. Commercial EXAMPLE 5 charcoal-cellulose acetate filter was effective in reducing the increase in photoactivation when compared to the unfiltered cigarette; however, the activity was twice that observed when the chemical antioxidant filter was employed. Employing the activated carbon plus antioxidant filter, prepared as previously described, complete suppression oflight energy from the aqueous solution was obtained.
Evaluation of the Ability ofAntioxidants, Added Directly to the Trapping Solution, to Modify Cellular Toxicity of Cigarette Smoke.
Since antioxidants were protective when incorporated into 35 filters, studies were undertakento determine if the addition of antioxidants directly into the smoke trapping solution would modify the lethal effects of cigarette smoke extracts. To this end, glutat hione and/or DPPD were added in the amount of Counts 100 mg/lO ml of the Krebs-Ringer phosphate trapping'solu- 40 7 per tion and 1 ml of the resulting Smoke extract obtained from un- $38 53 ag filtered cigarettes was added to each flask which contained ap- Flask Filter extract initial cpm. proximately [.2 X 10 alveolar macrophages. None"; 2O 16 B None 14 26B ]C)PPD {{lld glutathione. 15; harcon f L Smok, m minutes E Chnrcoal plus DPPD and 1T 19 Flask In vitro added antioxidant extract 0 1'30 glumthmno' mlxrlmmtli Footnote to above table:
without phosphorous and counted. N0 photoactivity was manifested initially in all samples. When H 0 was added, photoactivation occurred to varying degrees in the aqueous smoke extract solution and was dependent upon filter employed.
Additional studies were conducted where smoke was passed G H DPPD plus glutathtono.
In agreement with our previous observation, aqueous exthrough 20 ml of toluene containing 2.5 diphenyloxazole and tracts of cigarette smoke were toxic to alveolar macrophages -bis-(2-5-phenyloxazolyl)'benzene to enhance detection of (Flask B and E Flask A and p ctively). in contrast to light energy emitted by the sample under study. When samples manifested cytotoxicity, the addition of the water soluble an- 60 were prepared and counted one minute following completion tioxidant, glutathione, and the lipid soluble antioxidant DPPD of preparation, the photoactivity of the toluene sample was into the smoke trapping solution markedly reduced the lethality creased approximately one thousandfold when smoke from an of cigarette smoke (Flasks C and H). Glutathione by itself did unfiltered cigarette was used (sample B vs. sample A). This not appear to exert significant protective effect. was significantly decreased 68 per cent when the DPPD-glu- These studies eliminate the possibility of a non-specific tathionic antioxidant filter was employed. mechanism ofprotection of antioxidants,and indicate that the I I addition of DPPD, or DPPD and glutathione to the KRP medium in vitro, will modify the toxic effects ofcigarette smoke on Activity in alveolar macro ha es. i
p g EXAMPLE 6 70 Sample Filter Smoke Counts/Minute Antioxidants and Photo-activation Studies. In a further effort to evaluate the role of DPPD antioxidant g I I 8 7:2 in reducing alveolar macrophage injury following exposure to C Cellulose Meme cigarette smoke extracts and to evaluate the concept of free D DPPD-Glutathione 15,775
radical generation by cigarette smoke, cigarette smoke was One ml of aqueous extract was placed in scintillation vial EXAMPLE 7 Influence of DPPD Antioxidant Filters on Lipid Soluble Antioxidant Activity of Plasma and Other Tissues of Smoke Exposed Rats.
Studies were also conducted to determine if DPPD antioxidant filters could modify certain specific biochemical events associated with cigarette smoke exposure. Plasma and tissue lipid soluble antioxidant activity was determined in normal, untreated control rats, and in rats exposed to smoke from five unfiltered cigarettes. In addition, groups of rats were also exposed to smoke from five regular filter (cellulose acetate) cigarettes and to smoke derived from five antioxidant filter (FIG. 1) cigarettes. Values below are listed as means standard error of mean and are derived from groups of rats number from 6 to 13.'Values of DPPD lipid antioxidants are expressed as microequivalents of antioxidant per milliliter of plasma or per gram of tissue.
These studies denote that exposure of rats to alternating environments of cigarette smoke and air, by means of a partial vacuum to draw in alternating amounts of air and smoke into an enclosed chamber in which the rats were housed, induces a profound fall in plasma lipid soluble antioxidant activity. The decrease is observed with as little as one cigarette. A regular commercially available cellulose acetate filter does not modify the 72 per cent decrease in plasma lipid antioxidants. However, the decrease observed when the DPPD lipid soluble antioxidant filter was employed was but 44 per cent. In other words, the animals exposed to smoke obtained from DPPD antioxidant filtered cigarettes had plasma antioxidant levels that were approximately per cent higher than that observed when regular filtered or nonfiltered cigarettes were employed. Thus, the depletion of plasma lipid soluble antioxidant activity which follows cigarette smoke exposure is significantly inhibited when DPPD antioxidants are incorporated directly into the cigarette filter.
Thus, by my invention, l have devised a novel filter comprising the lipid soluble antioxidant DPPD which can be readily adapted to reduce the toxicity of cigarette smoke. This chemical antioxidant additive can readily be incorporated by impregnation into conventional type filters or as inserts into conventional filters. The resulting cigarette, which has been smoked by the investigator and others, is a mild, pleasant smoke without appreciable loss of flavor or aroma.
lclaim:
l. A tobacco smoke filter comprising a cylindrical container having a cross-sectional dimension conforming to that of a tobacco smoke passage and defining a space having an inlet and outlet, said space being filled with a smoke permeable composition comprising N,N-diphenyl-p-phenylenediamine in an amount from about 0.025 to 0.500 grams to reduce the toxic effect of tobacco smoke passing through the container on alveolar macrophages, the amount used not being toxic to the smoker.
2. A tobacco smoke filter according to claim 1 in which the N,N-diphenylp-phenylenediamine is mixed with glutathione.
3. A tobacco smoke filter according to claim 1 wherein the N,N'-diphenyl-p-phenylenediamine is impregnated into a cellulosic smoke filtering material.
4. A tobacco smoke filter according to claim I wherein the N,N-diphenyl-p-phenylenediaminc is incorporated with activated charcoal.
5. A tobacco smoke filter according to claim 2 wherein the mixture is impregnated into a cellulose acetate filtering material.
6. A tobacco smoke filter adapted to remove undesirable components from tobacco smoke, said filter having a crosssectional dimension conforming to that of a tobacco smoke passage and comprising a carrier material and an amount of from 5 per cent to 70 per cent by weight based on the weight of said carrier of N,N'-diphenyl-p-phenylenediamine to reduce the toxic effect of tobacco smoke passing through said passage, the amount used not being toxic to the smoker.
Claims (5)
- 2. A tobacco smoke filter according to claim 1 in which the N, N''-diphenyl-p-phenylenediamine is mixed with glutathione.
- 3. A tobacco smoke filter according to claim 1 wherein the N,N''-diphenyl-p-phenylenediamine is impregnated into a cellulosic smoke filtering material.
- 4. A tobacco smoke filter according to claim 1 wherein the N,N''-diphenyl-p-phenylenediamine is incorporated with activated charcoal.
- 5. A tobacco smoke filter according to claim 2 wherein the mixture is impregnated into a cellulose acetate filtering material.
- 6. A tobacco smoke filter adapted to remove undesirable components from tobacco smoke, said filter having a cross-sectional dimension conforming to that of a tobacco smoke passage and comprising a carrier material and an amount of from 5 per cent to 70 per cent by weight based on the weight of said carrier of N,N''-diphenyl-p-phenylenediamine to reduce the toxic effect of tobacco smoke passing through said passage, the amount used not being toxic to the smoker.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7724770A | 1970-10-01 | 1970-10-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
US3658070A true US3658070A (en) | 1972-04-25 |
Family
ID=22136947
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US77247A Expired - Lifetime US3658070A (en) | 1970-10-01 | 1970-10-01 | Tobacco smoke filters |
Country Status (3)
Country | Link |
---|---|
US (1) | US3658070A (en) |
CA (1) | CA946698A (en) |
GB (1) | GB1306895A (en) |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5501238A (en) * | 1993-01-11 | 1996-03-26 | Von Borstel; Reid W. | Cigarette filter containing a humectant |
US5746231A (en) * | 1993-01-11 | 1998-05-05 | Craig Lesser | Tobacco smoke filter for removing toxic compounds |
US5839447A (en) * | 1993-01-11 | 1998-11-24 | Lesser; Craig | Cigarette filter containing microcapsules and sodium pyroglutamate |
US6209547B1 (en) | 1998-10-29 | 2001-04-03 | Philip Morris Incorporated | Cigarette filter |
EP1238594A2 (en) * | 2001-03-05 | 2002-09-11 | Ivo Pera | Tobacco smoke filter and relative composition made of antioxidant and mineral substances |
US20030183239A1 (en) * | 2000-09-12 | 2003-10-02 | Lesser Craig A. | Tobacco smoke filter |
US20040016436A1 (en) * | 2002-07-26 | 2004-01-29 | Charles Thomas | Adsorbents for smoking articles comprising a non-volatile organic compound applied using a supercritical fluid |
US20040173227A1 (en) * | 2003-02-18 | 2004-09-09 | Von Borstel Reid | Filter containing a metal phthalocyanine and a polycationic polymer |
US6911189B1 (en) | 1999-10-29 | 2005-06-28 | Philip Morris Usa Inc. | Filter for selective removal of a gaseous component |
US20050207846A1 (en) * | 2000-12-04 | 2005-09-22 | Nickelson Reva A | Method of in situ retrieval of contaminants or other substances using a barrier system and leaching solutions |
US20060093437A1 (en) * | 2000-12-04 | 2006-05-04 | Nickelson Reva A | Subsurface materials management and containment system |
US7216652B1 (en) | 1999-07-28 | 2007-05-15 | Philip Morris Usa Inc. | Smoking article wrapper with improved filler |
US20080295852A1 (en) * | 2005-04-15 | 2008-12-04 | Reemtsma Cigarettenfabriken Gmbh | Tobacco Smoke Filter |
US20090020132A1 (en) * | 2005-02-01 | 2009-01-22 | Reemtsma Cigarettenfabriken Gmbh | Filter cigarette |
US20110184356A1 (en) * | 2002-09-25 | 2011-07-28 | Lifewave Products, Llc | Biomolecular wearable apparatus |
US20120165596A1 (en) * | 2008-05-15 | 2012-06-28 | David Schmidt | Apparatus and Method of Stimulating Elevation of Glutathione Levels in a Subject |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1842266A (en) * | 1931-04-14 | 1932-01-19 | Calvin S Hicks | Toracco mixture |
US2152602A (en) * | 1937-06-09 | 1939-03-28 | Hercules Powder Co Ltd | Food product |
US2513002A (en) * | 1947-03-27 | 1950-06-27 | Universal Oil Prod Co | Stabilization of crops |
US2856293A (en) * | 1954-11-30 | 1958-10-14 | Universal Oil Prod Co | Stabilization of fatty materials |
US2968306A (en) * | 1956-02-29 | 1961-01-17 | Eastman Kodak Co | Tobacco smoke filter capable of selective removal of aldehydes |
US3127901A (en) * | 1960-07-22 | 1964-04-07 | Whitefield Harry | Absorbing composition for tobacco smoke |
US3340879A (en) * | 1967-01-16 | 1967-09-12 | Brown & Williamson Tobacco | Cigarette filters |
US3410282A (en) * | 1967-03-13 | 1968-11-12 | Eastman Kodak Co | Filter medium for removing hydrogen cyanide from tobacco smoke |
US3426765A (en) * | 1967-02-21 | 1969-02-11 | Celanese Corp | Tobacco smoke filters |
US3429318A (en) * | 1967-09-07 | 1969-02-25 | Eastman Kodak Co | Selective filter medium |
US3550600A (en) * | 1967-03-29 | 1970-12-29 | Brown & Williamson Tobacco | Cigarette filters |
-
1970
- 1970-10-01 US US77247A patent/US3658070A/en not_active Expired - Lifetime
-
1971
- 1971-08-31 GB GB4061571A patent/GB1306895A/en not_active Expired
- 1971-09-07 CA CA122,219A patent/CA946698A/en not_active Expired
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1842266A (en) * | 1931-04-14 | 1932-01-19 | Calvin S Hicks | Toracco mixture |
US2152602A (en) * | 1937-06-09 | 1939-03-28 | Hercules Powder Co Ltd | Food product |
US2513002A (en) * | 1947-03-27 | 1950-06-27 | Universal Oil Prod Co | Stabilization of crops |
US2856293A (en) * | 1954-11-30 | 1958-10-14 | Universal Oil Prod Co | Stabilization of fatty materials |
US2968306A (en) * | 1956-02-29 | 1961-01-17 | Eastman Kodak Co | Tobacco smoke filter capable of selective removal of aldehydes |
US3127901A (en) * | 1960-07-22 | 1964-04-07 | Whitefield Harry | Absorbing composition for tobacco smoke |
US3340879A (en) * | 1967-01-16 | 1967-09-12 | Brown & Williamson Tobacco | Cigarette filters |
US3426765A (en) * | 1967-02-21 | 1969-02-11 | Celanese Corp | Tobacco smoke filters |
US3410282A (en) * | 1967-03-13 | 1968-11-12 | Eastman Kodak Co | Filter medium for removing hydrogen cyanide from tobacco smoke |
US3550600A (en) * | 1967-03-29 | 1970-12-29 | Brown & Williamson Tobacco | Cigarette filters |
US3429318A (en) * | 1967-09-07 | 1969-02-25 | Eastman Kodak Co | Selective filter medium |
Cited By (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5746231A (en) * | 1993-01-11 | 1998-05-05 | Craig Lesser | Tobacco smoke filter for removing toxic compounds |
US5839447A (en) * | 1993-01-11 | 1998-11-24 | Lesser; Craig | Cigarette filter containing microcapsules and sodium pyroglutamate |
US5860428A (en) * | 1993-01-11 | 1999-01-19 | Craig Lesser | Cigarette filter containing a humectant |
US6164288A (en) * | 1993-01-11 | 2000-12-26 | Craig Lesser | Cigarette filter containing dry water and microcapsules |
US5501238A (en) * | 1993-01-11 | 1996-03-26 | Von Borstel; Reid W. | Cigarette filter containing a humectant |
US6530377B1 (en) | 1993-01-11 | 2003-03-11 | Filligent Limited | Cigarette filter containing dry water and a porphyrin |
US6595218B1 (en) | 1998-10-29 | 2003-07-22 | Philip Morris Incorporated | Cigarette filter |
US6209547B1 (en) | 1998-10-29 | 2001-04-03 | Philip Morris Incorporated | Cigarette filter |
US7216652B1 (en) | 1999-07-28 | 2007-05-15 | Philip Morris Usa Inc. | Smoking article wrapper with improved filler |
US6911189B1 (en) | 1999-10-29 | 2005-06-28 | Philip Morris Usa Inc. | Filter for selective removal of a gaseous component |
US20030183239A1 (en) * | 2000-09-12 | 2003-10-02 | Lesser Craig A. | Tobacco smoke filter |
US6792953B2 (en) | 2000-09-12 | 2004-09-21 | Filligent Limited | Tobacco smoke filter |
US20050166933A1 (en) * | 2000-09-12 | 2005-08-04 | Lesser Craig A. | Tobacco smoke filter |
US20060099036A1 (en) * | 2000-12-04 | 2006-05-11 | Nickelson Reva A | Method of installing subsurface barrier |
US7153061B2 (en) | 2000-12-04 | 2006-12-26 | Battelle Energy Alliance, Llc | Method of in situ retrieval of contaminants or other substances using a barrier system and leaching solutions |
US20050207846A1 (en) * | 2000-12-04 | 2005-09-22 | Nickelson Reva A | Method of in situ retrieval of contaminants or other substances using a barrier system and leaching solutions |
US20060093437A1 (en) * | 2000-12-04 | 2006-05-04 | Nickelson Reva A | Subsurface materials management and containment system |
US7278800B2 (en) | 2000-12-04 | 2007-10-09 | Battelle Energy Alliance, Llc | Method of installing subsurface barrier |
US7121765B2 (en) * | 2000-12-04 | 2006-10-17 | Battelle Energy Alliance, Llc | Subsurface materials management and containment system |
EP1238594A3 (en) * | 2001-03-05 | 2004-03-17 | Ivo Pera | Tobacco smoke filter and relative composition made of antioxidant and mineral substances |
EP1238594A2 (en) * | 2001-03-05 | 2002-09-11 | Ivo Pera | Tobacco smoke filter and relative composition made of antioxidant and mineral substances |
US20040016436A1 (en) * | 2002-07-26 | 2004-01-29 | Charles Thomas | Adsorbents for smoking articles comprising a non-volatile organic compound applied using a supercritical fluid |
US20090272391A1 (en) * | 2002-07-26 | 2009-11-05 | Charles Thomas | Adsorbents for smoking articles comprising a non-volatile organic compound applied using a supercritical fluid |
US8114475B2 (en) * | 2002-07-26 | 2012-02-14 | Philip Morris Usa Inc. | Adsorbents for smoking articles comprising a non-volatile organic compound applied using a supercritical fluid |
US9943672B2 (en) | 2002-09-25 | 2018-04-17 | Lifewave, Inc. | Biomolecular wearable apparatus |
US8734316B2 (en) | 2002-09-25 | 2014-05-27 | Lifewave, Inc. | Biomolecular wearable apparatus |
US20110184356A1 (en) * | 2002-09-25 | 2011-07-28 | Lifewave Products, Llc | Biomolecular wearable apparatus |
US20060278249A1 (en) * | 2003-02-18 | 2006-12-14 | Von Borstel Reid | Filter containing a metal phthalocyanine and a polycationic polymer |
US20060289023A1 (en) * | 2003-02-18 | 2006-12-28 | Von Borstel Reid | Filter containing a metal phthalocyanine and polycationic polymer |
US7104265B2 (en) | 2003-02-18 | 2006-09-12 | Filligent Limited | Filter containing a metal phthalocyanine and a polycationic polymer |
US20040173227A1 (en) * | 2003-02-18 | 2004-09-09 | Von Borstel Reid | Filter containing a metal phthalocyanine and a polycationic polymer |
US8439046B2 (en) * | 2005-02-01 | 2013-05-14 | Reemtsma Cigarettenfabriken Gmbh | Filter cigarette |
US20090020132A1 (en) * | 2005-02-01 | 2009-01-22 | Reemtsma Cigarettenfabriken Gmbh | Filter cigarette |
US20080295852A1 (en) * | 2005-04-15 | 2008-12-04 | Reemtsma Cigarettenfabriken Gmbh | Tobacco Smoke Filter |
US20120165596A1 (en) * | 2008-05-15 | 2012-06-28 | David Schmidt | Apparatus and Method of Stimulating Elevation of Glutathione Levels in a Subject |
US8602961B2 (en) * | 2008-05-15 | 2013-12-10 | Lifewave Products Llc | Apparatus and method of stimulating elevation of glutathione levels in a subject |
US9149451B1 (en) | 2008-05-15 | 2015-10-06 | Lifewave, Inc. | Apparatus and method of stimulating elevation of glutathione levels in a subject |
US9532942B2 (en) | 2008-05-15 | 2017-01-03 | Lifewave, Inc. | Apparatus and method of stimulating elevation of glutathione levels in a subject |
Also Published As
Publication number | Publication date |
---|---|
GB1306895A (en) | 1973-02-14 |
CA946698A (en) | 1974-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3658070A (en) | Tobacco smoke filters | |
US3236244A (en) | Tobacco smoke filter element | |
JP3966856B2 (en) | Activated carbon filter for reducing p-benzosemiquinone from tobacco mainstream smoke | |
US4532947A (en) | Filter for reducing the toxic effects of cigarette tobacco smoke | |
RU2010545C1 (en) | Cigarette filter | |
US6415798B1 (en) | Antioxidants to neutralize tobacco free radicals | |
SK120496A3 (en) | Tobacco products, or substances similar to such products, containing natural substances with anti-oxidant properties, and process for producing the same | |
CA2760265C (en) | Cigarette filter | |
US3403689A (en) | Paper filter of selective removal of a cigarette smoke vapor | |
JPH0775535B2 (en) | Filter for cigarette combustion gas | |
IL46461A (en) | Process for the manufacture of tobacco compositions | |
US3802441A (en) | Tobacco smoke filter additive | |
US3889691A (en) | Tobacco smoke filter | |
EP1309253B1 (en) | Methods and devices for removing nucleophilic toxins from tobacco and tobacco smoke | |
US3498299A (en) | Filtration of tobacco smoke | |
US2920629A (en) | Filtration of tobacco smoke | |
CA1050254A (en) | Tobacco composition | |
RU2045921C1 (en) | Cigarette filter | |
CN108579270A (en) | A kind of net tobacco powder end of air | |
GB932570A (en) | Improvements relating to tobacco smoke filters | |
US3390688A (en) | Filter for removing oxides of nitrogen from tobacco smoke | |
JPH0523159A (en) | Cigarette filter | |
US3661160A (en) | Tobacco smoke filter | |
JPH02138958A (en) | Deodorant for tobacco filter and tobacco filter | |
JPH0383571A (en) | Filter for health-promoting tobacco, pipe, cigarette holder and the like having deodorizing, germicidal, far infrared-radiating and antistatic properties |